Pub Date : 2024-02-21DOI: 10.29011/2689-7407.100159
{"title":"Human Radiation-Induced Eye Diseases: A Scoping Review towards “In-silico” Experimental Studies","authors":"","doi":"10.29011/2689-7407.100159","DOIUrl":"https://doi.org/10.29011/2689-7407.100159","url":null,"abstract":"","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"6 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140444884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-13DOI: 10.29011/2689-7407.100156
Introduction: we reported a rare case involving chronic ICL V4c deposits after surgery without any other clinical manifestations. The deposits was found one month after surgery, and last about six weeks. After using topical steroid, the deposits were removed gradually. Patient and Clinical Findings: A 24-year-old female presented with granular opacity of implantable collamer lens (ICL) from one month after surgery (OS). There were no other inflammatory responses in the anterior segment of the eye. Diagnosis, Intervention, and Outcomes: The patient was diagnosed as chronic deposits on implantable collamer lens after surgery. After using 1% Prednisolone Acetate Eye Drop, the deposits were removed gradually. Conclusions: After ICL surgery, it is very uncommon for the chronic deposits to form on the ICL surface. Topical steroids was effective to help eliminate the deposits.
{"title":"Chronic Deposits on Implantable Collamer Lens after Surgery","authors":"","doi":"10.29011/2689-7407.100156","DOIUrl":"https://doi.org/10.29011/2689-7407.100156","url":null,"abstract":"Introduction: we reported a rare case involving chronic ICL V4c deposits after surgery without any other clinical manifestations. The deposits was found one month after surgery, and last about six weeks. After using topical steroid, the deposits were removed gradually. Patient and Clinical Findings: A 24-year-old female presented with granular opacity of implantable collamer lens (ICL) from one month after surgery (OS). There were no other inflammatory responses in the anterior segment of the eye. Diagnosis, Intervention, and Outcomes: The patient was diagnosed as chronic deposits on implantable collamer lens after surgery. After using 1% Prednisolone Acetate Eye Drop, the deposits were removed gradually. Conclusions: After ICL surgery, it is very uncommon for the chronic deposits to form on the ICL surface. Topical steroids was effective to help eliminate the deposits.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135923362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-13DOI: 10.29011/2689-7407.100054
S Crăiţoiu
{"title":"Bilateral Retinoblastoma","authors":"S Crăiţoiu","doi":"10.29011/2689-7407.100054","DOIUrl":"https://doi.org/10.29011/2689-7407.100054","url":null,"abstract":"","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134989484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammed Bin Maneea, A. Maqbool, A. Alzahrani, Alhanouf Alatawi, Ohoud Owaidhah
MicroPulse transscleral cyclophotocoagulation (MP-TSCPC) is a relatively new procedure for treating refractory advanced glaucoma. It uses repetitive micropulses of diode laser in an "on-off" cyclic manner, delivered with the Cyclo G6 Glaucoma Laser System (IRIDEX Corp., Mountain View, CA). In this unique case, we report the only instance of bilateral Urrets Zavalia Syndrome (UZS) in medical literature following MP-TSCPC in a 33-year-old Asian female with refractory angle-closure glaucoma. The patient developed bilateral fixed dilated pupils (UZS) after the treatment. The treatment settings included 100 seconds of laser application (50 seconds superiorly and 50 seconds inferiorly). Treated areas were the superior and inferior 180 degrees of the eye, excluding the 3 and 9 o'clock positions. On the first postoperative day, vision and intraocular pressure (IOP) were stable. Six weeks postoperatively, the patient presented with fixed mid-dilated pupils bilaterally and a visual acuity (VA) of 20/200 and 20/300, despite discontinuing Atropine 1% for 42 days. The patient was given pilocarpine 2% for ten days without response; however, vision improved to 20/125 and 20/160 with refraction and a +4.50 add for near vision. One and a half years postoperatively, the patient showed spontaneous partial recovery of the fixed dilated pupils in both eyes, with sectoral paralytic iris superiorly. The overall pupils' size was smaller in both eyes compared to previous visits. This case outlines the patient's symptoms, treatment, and outcome while discussing the potential risk of UZS following MP-TSCPC in specific populations. Further research is needed to better understand and mitigate the UZS complication after MP-TSCPC.
{"title":"Bilateral Fixed Dilated Pupils after MicroPulse Transscleral Cyclophotocoagulation: A Case Report and Review of Urrets-Zavalia Syndrome","authors":"Mohammed Bin Maneea, A. Maqbool, A. Alzahrani, Alhanouf Alatawi, Ohoud Owaidhah","doi":"10.33425/2639-9482.1028","DOIUrl":"https://doi.org/10.33425/2639-9482.1028","url":null,"abstract":"MicroPulse transscleral cyclophotocoagulation (MP-TSCPC) is a relatively new procedure for treating refractory advanced glaucoma. It uses repetitive micropulses of diode laser in an \"on-off\" cyclic manner, delivered with the Cyclo G6 Glaucoma Laser System (IRIDEX Corp., Mountain View, CA). In this unique case, we report the only instance of bilateral Urrets Zavalia Syndrome (UZS) in medical literature following MP-TSCPC in a 33-year-old Asian female with refractory angle-closure glaucoma. The patient developed bilateral fixed dilated pupils (UZS) after the treatment. The treatment settings included 100 seconds of laser application (50 seconds superiorly and 50 seconds inferiorly). Treated areas were the superior and inferior 180 degrees of the eye, excluding the 3 and 9 o'clock positions. On the first postoperative day, vision and intraocular pressure (IOP) were stable. Six weeks postoperatively, the patient presented with fixed mid-dilated pupils bilaterally and a visual acuity (VA) of 20/200 and 20/300, despite discontinuing Atropine 1% for 42 days. The patient was given pilocarpine 2% for ten days without response; however, vision improved to 20/125 and 20/160 with refraction and a +4.50 add for near vision. One and a half years postoperatively, the patient showed spontaneous partial recovery of the fixed dilated pupils in both eyes, with sectoral paralytic iris superiorly. The overall pupils' size was smaller in both eyes compared to previous visits. This case outlines the patient's symptoms, treatment, and outcome while discussing the potential risk of UZS following MP-TSCPC in specific populations. Further research is needed to better understand and mitigate the UZS complication after MP-TSCPC.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82278820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bilé Pefk, Konan Msmp, Diomandé Gf, Koffi Kfk, Gode Le, Goule Am, Babajeyu Rlo, D. Z, O. Y, Diomandé Ia
Primary open-angle glaucoma is a chronically progressive anterior optic neuropathy characterized by perimetric changes and pathological excavation of the optic disc. It is recognized as a disease that affects quality of life, social and professional life. If seen late or not treated, it can be disabling for all workers by making them medically unfit for their jobs. The prevention of occupational deintegration and job retention are important public health issues today. We report on 350 (700 eyes) glaucoma patients screened during a medical ophthalmological visit in the context of preparation for a public competition, which took place over 24 days in Yamoussoukro. The objective of this study was to determine the prevalence of primary open-angle glaucoma in candidates for a public competition.
{"title":"Prevalence of Primary Open-Angle Glaucoma in Candidates for a Public Competition","authors":"Bilé Pefk, Konan Msmp, Diomandé Gf, Koffi Kfk, Gode Le, Goule Am, Babajeyu Rlo, D. Z, O. Y, Diomandé Ia","doi":"10.33425/2639-9482.1027","DOIUrl":"https://doi.org/10.33425/2639-9482.1027","url":null,"abstract":"Primary open-angle glaucoma is a chronically progressive anterior optic neuropathy characterized by perimetric changes and pathological excavation of the optic disc. It is recognized as a disease that affects quality of life, social and professional life. If seen late or not treated, it can be disabling for all workers by making them medically unfit for their jobs. The prevention of occupational deintegration and job retention are important public health issues today. We report on 350 (700 eyes) glaucoma patients screened during a medical ophthalmological visit in the context of preparation for a public competition, which took place over 24 days in Yamoussoukro. The objective of this study was to determine the prevalence of primary open-angle glaucoma in candidates for a public competition.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88590415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oderinlo Olufemi, Hassan Adekunle, O. Idris, Odubela Tolulope, L. Oshunkoya
Aims and Objectives: To report a comparison of visual outcomes between patients treated with intravitreal ranibizumab and bevacizumab for diabetic macula oedema (DME) in a real-world setting in sub-Saharan Africa. Methods: A retrospective review of cases files of patients who were treated with either intravitreal ranibizumab or bevacizumab for diabetic macular edema in Eye Foundation Hospital Ikeja, Lagos, Nigeria between January 2018, and January 2019. Results: A total of 508 injections were received by 138 eyes of 115 patients within the study year and diabetic macular edema accounted for 36 eyes, (26.1%) of the total eyes that received either intravitreal Ranibizumab or Bevacizumab. There were 18 males (50%) and 18 (50%) females. Overall, the mean baseline pre injection BCVA was 0.32 ± 0.24 (range:0.05-1.0). One hundred and forty-three total injections of either Bevacizumab or Ranibizumab were received by the 36 eyes of DME participants. Fifteen eyes (41.7%) received Bevacizumab while 21 eyes (58.3%) received Ranibizumab injections. At 4 months a larger percentage of eyes (47.6%) that received Ranibizumab had better visual acuities compared to (13.3%) eyes that received Bevacizumab. At 6 months, more of the eyes that received Ranibizumab had better visual acuities (26.7%) compared to 23.8% that received Bevacizumab. At 9 months, more of the eyes that received Ranibizumab had better visual acuities (33.3%) compared to (19%) those that received Bevacizumab. However, these differences were not statistically significant. Compliance to treatment regime was poor, only 7 eyes of the 36 eyes (19.4%) were compliant, 5 eyes (33.3%) form Bevacizumab group and 2 eyes (9.5%) from the Ranibizumab group. Conclusion: Despite poor compliance, improvements in best corrected visual acuities was achieved and maintained with the use of either intravitreal bevacizumab or ranibizumab for diabetic macula edema in a real life setting in sub-Saharan Africa. Neither bevacizumab nor ranibizumab showed statistically significant superiority.
{"title":"A Comparison of Visual Outcomes Between Patients Treated with Intravitreal Ranibizumab and Bevacizumab for Diabetic Macula Edema in A Real World Setting in Sub-Saharan Africa","authors":"Oderinlo Olufemi, Hassan Adekunle, O. Idris, Odubela Tolulope, L. Oshunkoya","doi":"10.33425/2639-9482.1026","DOIUrl":"https://doi.org/10.33425/2639-9482.1026","url":null,"abstract":"Aims and Objectives: To report a comparison of visual outcomes between patients treated with intravitreal ranibizumab and bevacizumab for diabetic macula oedema (DME) in a real-world setting in sub-Saharan Africa. Methods: A retrospective review of cases files of patients who were treated with either intravitreal ranibizumab or bevacizumab for diabetic macular edema in Eye Foundation Hospital Ikeja, Lagos, Nigeria between January 2018, and January 2019. Results: A total of 508 injections were received by 138 eyes of 115 patients within the study year and diabetic macular edema accounted for 36 eyes, (26.1%) of the total eyes that received either intravitreal Ranibizumab or Bevacizumab. There were 18 males (50%) and 18 (50%) females. Overall, the mean baseline pre injection BCVA was 0.32 ± 0.24 (range:0.05-1.0). One hundred and forty-three total injections of either Bevacizumab or Ranibizumab were received by the 36 eyes of DME participants. Fifteen eyes (41.7%) received Bevacizumab while 21 eyes (58.3%) received Ranibizumab injections. At 4 months a larger percentage of eyes (47.6%) that received Ranibizumab had better visual acuities compared to (13.3%) eyes that received Bevacizumab. At 6 months, more of the eyes that received Ranibizumab had better visual acuities (26.7%) compared to 23.8% that received Bevacizumab. At 9 months, more of the eyes that received Ranibizumab had better visual acuities (33.3%) compared to (19%) those that received Bevacizumab. However, these differences were not statistically significant. Compliance to treatment regime was poor, only 7 eyes of the 36 eyes (19.4%) were compliant, 5 eyes (33.3%) form Bevacizumab group and 2 eyes (9.5%) from the Ranibizumab group. Conclusion: Despite poor compliance, improvements in best corrected visual acuities was achieved and maintained with the use of either intravitreal bevacizumab or ranibizumab for diabetic macula edema in a real life setting in sub-Saharan Africa. Neither bevacizumab nor ranibizumab showed statistically significant superiority.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85272675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Syeed Mehbub Ul Kadir, Rokhsanda Rehnuma, S. Rahman, M. Z. Raihani, Mahar Ali, Muhammad Moniruzzaman
Artificial intelligence (AI) is an emerging continuous equipment-based power that is initiating to spread throughout to all aspects of our lifestyles for digital revolution even in medical diagnosis, management of the disease AI application in ophthalmology can help in screening, diagnosing, staging, and providing best possible management planning of various eye diseases especially for sight-threatening eye conditions. This paper demonstrates a review of the art of AI in the ophthalmic field and focusing on the applications of AI for the diagnosis and treatment of ophthalmic diseases including cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity, and future AI applications with image enhancement in Ophthalmology. Diabetic retinopathy is occurring due to damage of retinal blood. Advanced diabetic retinopathy can cause blindness. So, early detection and management of diabetic retinopathy is crucial to prevent vision loss. AI based technology is playing a role as an auxiliary assistant in screening and diagnostic support for ophthalmologist.
{"title":"Artificial Intelligence (AI) in Ophthalmology: An Overview","authors":"Syeed Mehbub Ul Kadir, Rokhsanda Rehnuma, S. Rahman, M. Z. Raihani, Mahar Ali, Muhammad Moniruzzaman","doi":"10.33425/2639-9482.1024","DOIUrl":"https://doi.org/10.33425/2639-9482.1024","url":null,"abstract":"Artificial intelligence (AI) is an emerging continuous equipment-based power that is initiating to spread throughout to all aspects of our lifestyles for digital revolution even in medical diagnosis, management of the disease AI application in ophthalmology can help in screening, diagnosing, staging, and providing best possible management planning of various eye diseases especially for sight-threatening eye conditions. This paper demonstrates a review of the art of AI in the ophthalmic field and focusing on the applications of AI for the diagnosis and treatment of ophthalmic diseases including cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity, and future AI applications with image enhancement in Ophthalmology. Diabetic retinopathy is occurring due to damage of retinal blood. Advanced diabetic retinopathy can cause blindness. So, early detection and management of diabetic retinopathy is crucial to prevent vision loss. AI based technology is playing a role as an auxiliary assistant in screening and diagnostic support for ophthalmologist.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76708558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Primary Open Angle Glaucoma (POAG) is a serious condition responsible for irreversible blindness. It is one of the main causes of blindness in developing countries. Purpose: To assess the knowledges, attitudes and practices relating to Primary Open Angle Glaucoma (POAG) in the adult population in northern Benin. Patients and methods: This was a cross-sectional descriptive and analytical study. It concerned all persons aged 18 years old and over. We had done a two-stage sampling. The Chi2 test, at the 5% threshold, had been used to study the associations. Results: Of a total of 560 subjects, 548 (97.85%) participated in the study. The mean age was 33.1 ± 16.5 years. The male sex was more represented (61.13%) with a sex ratio of 1.57. The secondary level was represented with 46.35% (n = 254) and as an occupation, 22.63% (n = 124) were traders. 70.99% (n = 389) of subjects had heard of eye disease, of which only 8.76% (n = 48) had heard of glaucoma. It is called Naradiou in Bariba. But only 1.24% had a good knowledge of the disease. 50% (n = 24) did not known the cause, 4.17% (n = 2) attributed it to the curse and 2.08% (n = 1) to witchcraft. 72.50% (n = 35) knew that glaucoma could progress to blindness and 59.09% (n = 13) thought it was irreversible. 79.17% (n = 38) of subjects knew that there is a treatment, 52.63% (n = 20) said it was medical, 36.84% (n = 14) said it was surgical and 10, 53% (n = 4) thought it is traditional. The attitude was bad in 57.74% of the cases. Education and occupation were significantly associated with glaucoma knowledge and practice, but only gender was statistically related to attitude with a p-value of 0.0052. Conclusion: The level of knowledge of POAG in the adult population in northern Benin is alarming, as is the attitude and the practice which remains to be improved. Communication programs for behavior change must be initiated in order to reduce the rate of blindness linked to this pathology in this population.
{"title":"Knowledges, Attitudes and Practices Related to Primitive Open Angle Glaucoma in The Adult Population in Northern Benin","authors":"Assavedo Codjo Rodrigue Abel, Amedome Kokou Messan, A. Amadou, Abouki Chakiratou Oladouke, Monteiro Salimatou, Dionadji Memlelem Laeticia, Alamou Soulé, Sounouvou Ignace, O. Lisette, Tchabi Hounnou Sidonie","doi":"10.33425/2639-9482.1020","DOIUrl":"https://doi.org/10.33425/2639-9482.1020","url":null,"abstract":"Introduction: Primary Open Angle Glaucoma (POAG) is a serious condition responsible for irreversible blindness. It is one of the main causes of blindness in developing countries. Purpose: To assess the knowledges, attitudes and practices relating to Primary Open Angle Glaucoma (POAG) in the adult population in northern Benin. Patients and methods: This was a cross-sectional descriptive and analytical study. It concerned all persons aged 18 years old and over. We had done a two-stage sampling. The Chi2 test, at the 5% threshold, had been used to study the associations. Results: Of a total of 560 subjects, 548 (97.85%) participated in the study. The mean age was 33.1 ± 16.5 years. The male sex was more represented (61.13%) with a sex ratio of 1.57. The secondary level was represented with 46.35% (n = 254) and as an occupation, 22.63% (n = 124) were traders. 70.99% (n = 389) of subjects had heard of eye disease, of which only 8.76% (n = 48) had heard of glaucoma. It is called Naradiou in Bariba. But only 1.24% had a good knowledge of the disease. 50% (n = 24) did not known the cause, 4.17% (n = 2) attributed it to the curse and 2.08% (n = 1) to witchcraft. 72.50% (n = 35) knew that glaucoma could progress to blindness and 59.09% (n = 13) thought it was irreversible. 79.17% (n = 38) of subjects knew that there is a treatment, 52.63% (n = 20) said it was medical, 36.84% (n = 14) said it was surgical and 10, 53% (n = 4) thought it is traditional. The attitude was bad in 57.74% of the cases. Education and occupation were significantly associated with glaucoma knowledge and practice, but only gender was statistically related to attitude with a p-value of 0.0052. Conclusion: The level of knowledge of POAG in the adult population in northern Benin is alarming, as is the attitude and the practice which remains to be improved. Communication programs for behavior change must be initiated in order to reduce the rate of blindness linked to this pathology in this population.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"112 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87926671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: We present a case of a young Caucasian myopic patient with secondary ACG and the management during her pregnancy amidst the COVID-19 pandemic. Angle closure glaucoma (ACG) is an uncommon condition in younger myopic individuals. Thus, ACG in pregnancy is not well researched and no definitive guidelines exist for its treatment. Case Report: This 27-year-old female patient had been diagnosed with hypertensive uveitis and referred to the glaucoma clinic where peripheral anterior synechiae (PAS) was noticed on gonioscopy. As she had subacute angle closure glaucoma symptoms, she had been started on topical pilocarpine drops. She remained stable and under our regular follow up (dates). At her review in January 2021, she notified us that she was 27 weeks pregnant. She had continued pilocarpine drops once a day. Pilocarpine is a category C drug (with potential foetal risk though lack of human studies). Pilocarpine was advised to be stopped in the clinic as intra-ocular pressure is known to stabilise during pregnancy. She was further reviewed in the third trimester and had an uneventful delivery with a healthy baby. Her last review was post-pregnancy. She remained asymptomatic and her intra-ocular pressures were stable for the entire duration. Conclusion: Our case was an unusual presentation of subacute angle closure secondary to PAS in a young myopic female. Her management of pregnancy in the COVID-19 pandemic when secondary to the social distancing rules was challenging as the clinic reviews are limited. We successfully managed timely reviews without risking the patient or the baby of any potential side effects to pilocarpine or COVID-19.
{"title":"Management of Angle Closure Glaucoma in a Myopic Pregnant Woman during the COVID-19 Pandemic – A Case Journey","authors":"Shivani Sharma, M. Chakrabarti, T. Sharma","doi":"10.33425/2639-9482.1021","DOIUrl":"https://doi.org/10.33425/2639-9482.1021","url":null,"abstract":"Introduction: We present a case of a young Caucasian myopic patient with secondary ACG and the management during her pregnancy amidst the COVID-19 pandemic. Angle closure glaucoma (ACG) is an uncommon condition in younger myopic individuals. Thus, ACG in pregnancy is not well researched and no definitive guidelines exist for its treatment. Case Report: This 27-year-old female patient had been diagnosed with hypertensive uveitis and referred to the glaucoma clinic where peripheral anterior synechiae (PAS) was noticed on gonioscopy. As she had subacute angle closure glaucoma symptoms, she had been started on topical pilocarpine drops. She remained stable and under our regular follow up (dates). At her review in January 2021, she notified us that she was 27 weeks pregnant. She had continued pilocarpine drops once a day. Pilocarpine is a category C drug (with potential foetal risk though lack of human studies). Pilocarpine was advised to be stopped in the clinic as intra-ocular pressure is known to stabilise during pregnancy. She was further reviewed in the third trimester and had an uneventful delivery with a healthy baby. Her last review was post-pregnancy. She remained asymptomatic and her intra-ocular pressures were stable for the entire duration. Conclusion: Our case was an unusual presentation of subacute angle closure secondary to PAS in a young myopic female. Her management of pregnancy in the COVID-19 pandemic when secondary to the social distancing rules was challenging as the clinic reviews are limited. We successfully managed timely reviews without risking the patient or the baby of any potential side effects to pilocarpine or COVID-19.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"145 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91384535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Assavedo Codjo Rodrigue Abel, Alfa Bio Amadou Issifou, Sina Zabdi, Monteiro Salimatou, Abouki Chakiratou, Alamou Soulé, Tchabi Hounnou Sidonie
Introduction: Diabetic retinopathy is one of the main causes of blindness. Preventive measures and screening will reduce its impact. Objective: Study the knowledges, attitudes and practices of diabetic patients about diabetic retinopathy from 03 hospitals in the District of Parakou in 2019. Methods: The study was carried out in 03 hospitals in northern Benin (University and Regional Health Center of Borgou and Alibori, Army Health Center of Parakou, and the Diabetes Center of Benin. This was a descriptive and analytical cross-sectional prospective study that covered a period of 03 months from 15th May to 20th August, 2019. The sampling method was non-probability. Selection of diabetic patients was exhaustive taking care for the consent of each patient. The aged group was at least 18 years old and above, resident in Parakou and followed up in one of the above heath centers. We enrolled 150 patients after submitted them to some questionnaires. Results: From the total number of 150 patients, 59.33% were male. The mean age was 55.07 ± 11.62 years. The participants were predominantly married (87.33%) and 62% of them were literate. 48% of patients said diabetes mellitus is responsible of eye complications. 52% and 12% of patients reported that balancing blood sugar and normalizing blood pressure, respectively, are preventative factors for diabetic retinopathy. 27.33% of patients reported the need for a regular eye fundus exam. 12.67% of patients have a regular annual eye fundus examination and 56.67% of patients have never had one. Education and gender were associated with level of knowledges; education and low income were associated with level of practices. Conclusion: Reducing the impact of diabetic retinopathy requires better involvement of the diabetic patient, the ophthalmologist, the endocrinologist and the authorities of the Ministry of Health.
{"title":"Knowledges, Attitudes and Practices of Diabetic Patients Face to Diabetic Retinopathy in Parakou in 2019","authors":"Assavedo Codjo Rodrigue Abel, Alfa Bio Amadou Issifou, Sina Zabdi, Monteiro Salimatou, Abouki Chakiratou, Alamou Soulé, Tchabi Hounnou Sidonie","doi":"10.33425/2639-9482.1016","DOIUrl":"https://doi.org/10.33425/2639-9482.1016","url":null,"abstract":"Introduction: Diabetic retinopathy is one of the main causes of blindness. Preventive measures and screening will reduce its impact. Objective: Study the knowledges, attitudes and practices of diabetic patients about diabetic retinopathy from 03 hospitals in the District of Parakou in 2019. Methods: The study was carried out in 03 hospitals in northern Benin (University and Regional Health Center of Borgou and Alibori, Army Health Center of Parakou, and the Diabetes Center of Benin. This was a descriptive and analytical cross-sectional prospective study that covered a period of 03 months from 15th May to 20th August, 2019. The sampling method was non-probability. Selection of diabetic patients was exhaustive taking care for the consent of each patient. The aged group was at least 18 years old and above, resident in Parakou and followed up in one of the above heath centers. We enrolled 150 patients after submitted them to some questionnaires. Results: From the total number of 150 patients, 59.33% were male. The mean age was 55.07 ± 11.62 years. The participants were predominantly married (87.33%) and 62% of them were literate. 48% of patients said diabetes mellitus is responsible of eye complications. 52% and 12% of patients reported that balancing blood sugar and normalizing blood pressure, respectively, are preventative factors for diabetic retinopathy. 27.33% of patients reported the need for a regular eye fundus exam. 12.67% of patients have a regular annual eye fundus examination and 56.67% of patients have never had one. Education and gender were associated with level of knowledges; education and low income were associated with level of practices. Conclusion: Reducing the impact of diabetic retinopathy requires better involvement of the diabetic patient, the ophthalmologist, the endocrinologist and the authorities of the Ministry of Health.","PeriodicalId":92830,"journal":{"name":"Ophthalmology research and reports","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81448832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：